Abstract
Plasma levels of prolactin, before and after TRH stimulation, progesterone, estradiol, sex-hormone-binding-globulin, androstenedione, testosterone and dehydroepiandrosterone-sulphate were determined in a group of women with benign breast disease and in control group, in order to correlate a possible hormonal disorder to breast pathology. The hormonal pattern in the patients with benign breast disease was characterized by an increased responsiveness of lactotrophes to TRH stimulation and by higher levels of sex hormone binding globulin, probably sustained by an underlying hyperestrogenism.
Similar content being viewed by others
References
Welsch C.W., Dombroske S.E., MacManus M.J., Calaf J. Effect of human, bovine and ovine prolactin on DNA synthesis by organ cultures of benign breast tumors. Br. J. Cancer 40: 866, 1979.
Gorins A., Netter A. La prolactin, son dosage radioimmunologique dans le cancer sein et les mastopathies benigne de la femme. Nouv. Presse Med. 3: 73, 1974.
Malarkey W.B, Schroeder L.L., Stevens V.C., James A.G., Lanese R.R. Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Res. 37: 4650, 1977.
Rose D.P., Lahti H., Laakso K., Kettunen K., Wynder E.L. Serum and breast duct fluid prolactin and estrogen levels in healthy finnish and american women and patients with fibrocystic disease. Cancer 57: 1550, 1986.
Geller S., Scholler R., Amalric R., Ayme Y., Spitalier J.M. Le test combiné’ LHRH + TRH dans les mastopathies dites “hormonales”. Nouv. Presse Med. 7: 1563, 1978.
Peters F., Pickardt C.R., Zimmermann G., Breckwoldt M. PRL, TSH and thyroid hormones in benign breast disease. Klin. Wochenschr. 59: 403, 1981.
Peters F., Schuth W., Scheurich B., Breckwoldt M. Serum prolactin levels in patients with fibrocystic disease. Obstet. Gynecol. 49: 381, 1984.
Dogliotti L., Faggiuolo R., Ferusso A., Orlandi F., Sandrucci S., Tibo A, Angeli A. Prolactin and thyrotropin response to TRH in premenopausal women with fibrocystic disease of the breast. Horm. Res. 21: 137, 1985.
Kumac S., Mansel R.E., Hughes L.E., Edwards C.A., Scanion M.F. Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release. Clin. Endocrinol. (Oxf.) 23: 699, 1985.
Mauvais-Jarvis P., Kutten F., Mowszcowicz J., Sitruk-Ware R. Mastopathies benignes: étude hormonale chez 125 malades. Nouv. Presse Med. 6: 4115, 1977.
Walsh P.V., Bulbrook R.D., Stell P.M., Wang D.J., McDicken J.W., George W.D. Serum progesterone concentration during the luteal phase in women with benign breast disease. Eur. J. Cancer Clin. Oncol. 20: 411, 1984.
Bruning P.F., Bonfrer J.M.G., Bobrow L., De Jong-Bakker M., Hart A.A.M., Misdorp W. Plasma hormones in premenopausal women with benign breast disease. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of the breast: basic and clinical aspects. Raven Press, New York, 1986, p. 579.
Miller W.R., Humeniuk V., Kelley R.W. Dehydroepiandrosterone sulphate in breast secretions. J. Steroid Biochem. 13: 143, 1980.
Bradlow H.L., Rosenfeld R.S, Kream J., Fleisher M., O’Connor J., Schwartz M.K. Steroid hormone accumulation in human breast cyst fluid. J. Clin. Endocrinol. Metab. 49: 778, 1981.
Miller W.R., Dixon J.M., Scott W.N., Forrest A.P.M. Classification of human breast cysts according to electrolyte and androgen conjugate composition. Clin. Oncol. 9: 227, 1983.
Dogliotti L., Orlandi F., Torta M., Buzzi G., Naldoni C., Mazzotti A., Angeli A. Cations and dehydroepiandrosterone-sulphate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the subpopulations of cysts. Eur.J. Clin. Oncol. 22: 1301, 1986.
Cole E.N., Sellwood R.A., England P.C., Griffiths K. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. Eur. J. Cancer 15: 1185, 1981.
Walsh P.V., McDicken I.W., Bulbrook R.D., Moore J.W., Taylor W.H., George W.D. Serum oestradiol-17β and prolactin concentrations during the luteal phase in women with benign breast disease. Eur. J. Cancer Clin. Oncol. 20: 1345, 1984.
Tarquini B., Gheri R., Romano S.R., Costa A., Cagnoni M., Lee J.K., Halberg F. Circadian variations of serum prolactin and TSH of women with health or with mammary carcinoma, fibroadenomata or fibrocystic mastopathy. Int. J. Chronobiol. 7: 101, 1980.
Vorherr H. Thyroid disease in realtion to breast cancer. Klin. Wochenschr. 56: 1139, 1978.
Massara F., Camanni F., Vergano V., Belforte L., Molinatti G.M. Inhibition of thyrotropin and prolactin secretion by dopamine in man. J. Endocrinol. Invest. 1: 25, 1978.
Scanlon M.F., Weightman D.R., Shale D.J., Mora B., Heath M., Snow G., Hall R. Dopamine is a physiological regulator of thyrotropin (TSH) secretion in normal man. Clin. Endocrinol. (Oxf.) 10: 7, 1979.
Rodriguez-Arnao M.D., Peters J.R., Foord S.M., Dieguez C., Edwards C., Gomez-Pan A., Hall R., Newcombe R.G., Scanlon M.F. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect. J. Clin. Endocrinol. Metab. 57: 975, 1983.
Leong D.A., Frawley L.S., Neill J.D. Neuroendocrine control of prolactin secretion. Ann. Rev. Physiol. 45: 109, 1983.
Melis G.B., Guameri G., Paoletti A.M., Petacchi F.D., Ricci G., Strigini F., Selli M., Ruiu A., Fioretti P. Clinical significance of hormonal evaluation in peripheral blood and in breast cyst fluid of women with benign breast disease. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of cystic breast disease. Raven Press, New York, 1983, p. 101.
Marchesoni D., Gangemi M., Mozzanega B., Nardelli G.B., Miggino T., Verlasco M. Hormonal investigation in benign breast disease. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of cystic breast disease. Raven Press, New York, 1983, p. 145.
England P.C., Skinner L.G., Cottrell K.M., Sellwood R.A. Sex hormones in breast disease. Br. J. Surg. 62: 806, 1975.
Swain M.C., Hayward J.L., Bulbrook R.D. Plasma estradiol and progesterone in benign breast disease. Eur. J. Cancer 9: 553, 1973.
Berta L., Frairia R., Bumma C., Navello C., Mossetti C., Rovero E., Gaidano G. Hormonal pattern and sex hormone binding globulin in plasma of women with cystic breast disease. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of cystic breast disease. Raven Press, New York, 1983, p. 123.
Carlstrom K., Doberl A., Gershagen S., Rannevik., Rasmussen T, Tobiassen T. Elevated peripheral levels of androgens and a some sensitive steroid plasma proteins in patients with severe fibrocystic breast disease. Acta Obstet. Gynecol. Scand. (Suppl.) 123: 157, 1984.
Kratochwil K., Durnberger H., Heuberger B., Wasner G. Hormone-induced cell and tissue interaction in the embryonic mammary gland. Cold Spring Harbor Conferences on Cell Proliferation 6: 717, 1979.
Miller W.R., Dixon J.M., Forrest P.M. Hormonal correlates of apocrine secretion in the breast. In: Angeli A., Bradlow H.L., Dogliotti L. (Eds.), Endocrinology of the breast: basic and clinical aspects, Raven press, New York, 1986, p. 275
Poortman J., Prenen J.A.C., Thijssen J.H.H., Schwarz F. Interaction of 5-androstene-3β-17β-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. J. Clin. Endocrinol. Metab. 40: 373, 1975.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parlati, E., Travaglini, A., Liberale, I. et al. Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients. J Endocrinol Invest 11, 679–683 (1988). https://doi.org/10.1007/BF03350214
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350214